Biomarkers distinguish HBeAg seroconverted from non-converted individuals in chronic hepatitis B patients treated with a therapeutic vaccine | |
Zhou, Xian; Geng, Shuang; Zhang, Shijie; Zhao, Weidong; Zhao, Gan; Wen, Yumei; Wang, Xuanyi; Wang, Bin | |
刊名 | CYTOKINE
![]() |
2018 | |
卷号 | 106 |
关键词 | Hepatitis B virus Antigen-antibody complex therapeutic vaccine Biomarker Boolean analysis model |
ISSN号 | 1043-4666 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3600729 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Zhou, Xian,Geng, Shuang,Zhang, Shijie,et al. Biomarkers distinguish HBeAg seroconverted from non-converted individuals in chronic hepatitis B patients treated with a therapeutic vaccine[J]. CYTOKINE,2018,106. |
APA | Zhou, Xian.,Geng, Shuang.,Zhang, Shijie.,Zhao, Weidong.,Zhao, Gan.,...&Wang, Bin.(2018).Biomarkers distinguish HBeAg seroconverted from non-converted individuals in chronic hepatitis B patients treated with a therapeutic vaccine.CYTOKINE,106. |
MLA | Zhou, Xian,et al."Biomarkers distinguish HBeAg seroconverted from non-converted individuals in chronic hepatitis B patients treated with a therapeutic vaccine".CYTOKINE 106(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论